Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like FDA Adds Morphine, Epinephrine to COVID-19 Compounding List May 21, 2020 Ridgeback Biotherapeutics to Launch Two Trials of Its COVID-19 Antiviral June 22, 2020 J&J Partners With Emergent to Produce COVID-19 Vaccine April 23, 2020